MCF Advisors’s Avanos Medical AVNS Stock Holding History

MCF Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4	Closed	–	–	452
2018 Q4	$0	Hold	4	–	–	﹤0.01%	477
2018 Q3	$0	Hold	4	–	–	﹤0.01%	466
2018 Q2	$0	Buy	+4	New	+$211	﹤0.01%	436
2018 Q1	–	Sell	-4	Closed	–	–	472
2017 Q4	$0	Sell	4 -15	-79%	-$689	﹤0.01%	480
2017 Q3	$1K	Hold	19	–	–	﹤0.01%	465
2017 Q2	$1K	Hold	19	–	–	﹤0.01%	465
2017 Q1	$1K	Hold	19	–	–	﹤0.01%	430
2016 Q4	$1K	Hold	19	–	–	﹤0.01%	421
2016 Q3	$1K	Hold	19	–	–	﹤0.01%	427
2016 Q2	$1K	Sell	19 -16	-46%	-$490	﹤0.01%	499
2016 Q1	$1K	Sell	35 -10	-22%	-$266	﹤0.01%	423
2015 Q4	$2K	Sell	45 -356	-89%	-$11.1K	﹤0.01%	418
2015 Q3	$11K	Hold	401	–	–	﹤0.01%	305
2015 Q2	$16K	Sell	401 -9	-2%	-$404	﹤0.01%	276
2015 Q1	$20K	Hold	410	–	–	0.01%	258
2014 Q4	$19K	Buy	+410	New	+$16.1K	0.01%	254

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCF Advisors's AVNS Position: Q1 2019 in Review

MCF Advisors sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 4 shares.

MCF Advisors first reported a position in AVNS in Q4 2014 and held it in 16 quarters. The position peaked at $20K in Q1 2015. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

MCF Advisors reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
MCF Advisors sold 4 Avanos Medical shares in Q1 2019.
MCF Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 16 quarters.
MCF Advisors's Avanos Medical position peaked at $20K in Q1 2015.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on MCF Advisors's 13F filing for Q1 2019, filed 7 May 2019.